Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip Chlap

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Clinical and Translational Radiation Oncology|March 14, 2022
Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in AustraliaWsam Ghandourh, Lois Holloway, Vikneswary Batumalai, et al.
Journal of Applied Clinical Medical Physics|July 26, 2022
Development of a vendor neutral MRI distortion quality assurance workflowAmy Walker, Phillip Chlap, Trent Causer, et al.
Journal of Medical Imaging and Radiation Oncology|June 19, 2021
A review of medical image data augmentation techniques for deep learning applicationsPhillip Chlap, Hang Min, Nym Vandenberg, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|October 17, 2020
Assessing tumor centrality in lung stereotactic ablative body radiotherapy (SABR): the effects of variations in bronchial tree delineation and potential for automated methodsWsam Ghandourh, Jason Dowling, Phillip Chlap, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2021
Variability of gross tumour volume delineation: MRI and CT based tumour and lymph node delineation for lung radiotherapyShivani Kumar, Lois Holloway, Miriam Boxer, et al.
Frontiers in Oncology|July 31, 2023
Assessment of intrafraction motion and its dosimetric impact on prostate radiotherapy using an in-house developed position monitoring systemSankar Arumugam, Tony Young, Viet Do, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 17, 2023
Mid-treatment 18F-FDG PET imaging changes in parotid gland correlates to radiation-induced xerostomiaYuvnik Trada, Mark T Lee, Michael G Jameson, et al.
Quantitative Imaging in Medicine and Surgery|June 11, 2026
Evaluation of mid-treatment <sup>18</sup>F-FDG PET changes in the oral cavity as a predictor of radiation-induced mucositis severityDaniel Mills, Phillip Chlap, Allan Fowler, et al.
Quantitative Imaging in Medicine and Surgery|May 14, 2023
Impact of tumour region of interest delineation method for mid-treatment FDG-PET response prediction in head and neck squamous cell carcinoma undergoing radiotherapyYuvnik Trada, Peter Lin, Mark T Lee, et al.
EJNMMI Research|April 1, 2025
Mid-treatment changes in intra-tumoural metabolic heterogeneity correlate to outcomes in oropharyngeal squamous cell carcinoma patientsYuvnik Trada, Mark T Lee, Michael G Jameson, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Clinical and Translational Radiation Oncology|March 14, 2022
Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in AustraliaWsam Ghandourh, Lois Holloway, Vikneswary Batumalai, et al.
Journal of Applied Clinical Medical Physics|July 26, 2022
Development of a vendor neutral MRI distortion quality assurance workflowAmy Walker, Phillip Chlap, Trent Causer, et al.
Journal of Medical Imaging and Radiation Oncology|June 19, 2021
A review of medical image data augmentation techniques for deep learning applicationsPhillip Chlap, Hang Min, Nym Vandenberg, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|October 17, 2020
Assessing tumor centrality in lung stereotactic ablative body radiotherapy (SABR): the effects of variations in bronchial tree delineation and potential for automated methodsWsam Ghandourh, Jason Dowling, Phillip Chlap, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2021
Variability of gross tumour volume delineation: MRI and CT based tumour and lymph node delineation for lung radiotherapyShivani Kumar, Lois Holloway, Miriam Boxer, et al.
Frontiers in Oncology|July 31, 2023
Assessment of intrafraction motion and its dosimetric impact on prostate radiotherapy using an in-house developed position monitoring systemSankar Arumugam, Tony Young, Viet Do, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 17, 2023
Mid-treatment 18F-FDG PET imaging changes in parotid gland correlates to radiation-induced xerostomiaYuvnik Trada, Mark T Lee, Michael G Jameson, et al.
Quantitative Imaging in Medicine and Surgery|June 11, 2026
Evaluation of mid-treatment <sup>18</sup>F-FDG PET changes in the oral cavity as a predictor of radiation-induced mucositis severityDaniel Mills, Phillip Chlap, Allan Fowler, et al.
Quantitative Imaging in Medicine and Surgery|May 14, 2023
Impact of tumour region of interest delineation method for mid-treatment FDG-PET response prediction in head and neck squamous cell carcinoma undergoing radiotherapyYuvnik Trada, Peter Lin, Mark T Lee, et al.
EJNMMI Research|April 1, 2025
Mid-treatment changes in intra-tumoural metabolic heterogeneity correlate to outcomes in oropharyngeal squamous cell carcinoma patientsYuvnik Trada, Mark T Lee, Michael G Jameson, et al.
Pageof 3